Literature DB >> 28513079

REM Sleep Behavior Disorder in Parkinson's Disease and Other Synucleinopathies.

Erik K St Louis1,2, Angelica R Boeve1,2, Bradley F Boeve1,2.   

Abstract

Rapid eye movement sleep behavior disorder is characterized by dream enactment and complex motor behaviors during rapid eye movement sleep and rapid eye movement sleep atonia loss (rapid eye movement sleep without atonia) during polysomnography. Rapid eye movement sleep behavior disorder may be idiopathic or symptomatic and in both settings is highly associated with synucleinopathy neurodegeneration, especially Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure. Rapid eye movement sleep behavior disorder frequently manifests years to decades prior to overt motor, cognitive, or autonomic impairments as the presenting manifestation of synucleinopathy, along with other subtler prodromal "soft" signs of hyposmia, constipation, and orthostatic hypotension. Between 35% and 91.9% of patients initially diagnosed with idiopathic rapid eye movement sleep behavior disorder at a sleep center later develop a defined neurodegenerative disease. Less is known about the long-term prognosis of community-dwelling younger patients, especially women, and rapid eye movement sleep behavior disorder associated with antidepressant medications. Patients with rapid eye movement sleep behavior disorder are frequently prone to sleep-related injuries and should be treated to prevent injury with either melatonin 3-12 mg or clonazepam 0.5-2.0 mg to limit injury potential. Further evidence-based studies about rapid eye movement sleep behavior disorder are greatly needed, both to enable accurate prognostic prediction of end synucleinopathy phenotypes for individual patients and to support the application of symptomatic and neuroprotective therapies. Rapid eye movement sleep behavior disorder as a prodromal synucleinopathy represents a defined time point at which neuroprotective therapies could potentially be applied for the prevention of Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure.
© 2017 International Parkinson and Movement Disorder Society. © 2017 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Dementia with Lewy bodies; Parkinson's disease; REM sleep behavior disorder; REM sleep without atonia; multiple system atrophy; polysomnography; pure autonomic failure; synucleinopathy; treatment

Mesh:

Substances:

Year:  2017        PMID: 28513079     DOI: 10.1002/mds.27018

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  40 in total

1.  Vulnerability of multiple large-scale brain networks in dementia with Lewy bodies.

Authors:  Arianna Sala; Silvia Paola Caminiti; Leonardo Iaccarino; Luca Beretta; Sandro Iannaccone; Giuseppe Magnani; Alessandro Padovani; Luigi Ferini-Strambi; Daniela Perani
Journal:  Hum Brain Mapp       Date:  2019-07-19       Impact factor: 5.038

2.  Center Predictors of Long-Term Benzodiazepine Use in Chronic Obstructive Pulmonary Disease and Post-traumatic Stress Disorder.

Authors:  Lucas M Donovan; Carol A Malte; Laura J Spece; Matthew F Griffith; Laura C Feemster; Steven B Zeliadt; David H Au; Eric J Hawkins
Journal:  Ann Am Thorac Soc       Date:  2019-09

3.  [Parkinson's syndromes in geriatric patients : Epidemiological, clinical and therapeutic characteristics].

Authors:  K Amadori; T Steiner
Journal:  Nervenarzt       Date:  2019-12       Impact factor: 1.214

4.  Prognostic Counseling for Patients With Idiopathic/Isolated REM Sleep Behavior Disorder: Should We Tell Them What's Coming? Yes.

Authors:  Erik K St Louis
Journal:  Mov Disord Clin Pract       Date:  2019-10-01

Review 5.  REM sleep behavior disorder, autonomic dysfunction and synuclein-related neurodegeneration: where do we stand?

Authors:  Giacomo Chiaro; Giovanna Calandra-Buonaura; Annagrazia Cecere; Francesco Mignani; Luisa Sambati; Giuseppe Loddo; Pietro Cortelli; Federica Provini
Journal:  Clin Auton Res       Date:  2017-09-04       Impact factor: 4.435

Review 6.  New evidence on the management of Lewy body dementia.

Authors:  John-Paul Taylor; Ian G McKeith; David J Burn; Brad F Boeve; Daniel Weintraub; Claire Bamford; Louise M Allan; Alan J Thomas; John T O'Brien
Journal:  Lancet Neurol       Date:  2019-09-10       Impact factor: 44.182

7.  The influences of behavioral and psychological interventions on the neurological function and MMSE scores in Parkinson's disease patients.

Authors:  Aimin Luo; Shuming Zhong; Shunkai Lai; Yanbin Jia
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

8.  Autonomic dysfunction and phenoconversion in idiopathic REM sleep behavior disorder.

Authors:  Stuart J McCarter; Tonette L Gehrking; Erik K St Louis; Mariana D Suarez; Bradley F Boeve; Michael H Silber; Phillip A Low; Wolfgang Singer
Journal:  Clin Auton Res       Date:  2020-03-19       Impact factor: 4.435

Review 9.  Diagnosis and Management of Cognitive and Behavioral Changes in Dementia With Lewy Bodies.

Authors:  Babak Tousi
Journal:  Curr Treat Options Neurol       Date:  2017-10-09       Impact factor: 3.598

10.  Normative and isolated rapid eye movement sleep without atonia in adults without REM sleep behavior disorder.

Authors:  John C Feemster; Youngsin Jung; Paul C Timm; Sarah M Westerland; Thomas R Gossard; Luke N Teigen; Lauren A Buchal; Elena F D Cattaneo; Charlotte A Imlach; Stuart J Mccarter; Kevin L Smith; Bradley F Boeve; Michael H Silber; Erik K St Louis
Journal:  Sleep       Date:  2019-10-09       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.